After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
SRPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Sarepta Therapeutics Inc is $5.22B. A total of 1.91 million shares were traded on the day, compared to an average of 1.85M shares.
In the most recent transaction, Nicaise Claude sold 2,491 shares of SRPT for 99.64 per share on Mar 12 ’25. After the transaction, the Director now owns 27,812 company shares. In a previous transaction on Mar 12 ’25, Nicaise Claude bought 2,491 shares at 99.65 per share.
Among the insiders who sold shares, Wigzell Hans Lennart Rudolf disposed of 10,500 shares on Dec 12 ’24 at a per-share price of $124.84. This resulted in the Director holding 22,840 shares of SRPT after the transaction. In another insider transaction, Wigzell Hans Lennart Rudolf bought 10,500 shares at $124.80 per share on Dec 12 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SRPT has a high of $173.25 and a low of $48.01.
As of this writing, SRPT has an earnings estimate of -$0.43 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $2.84 per share and a lower estimate of -$3.95.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $15.77, while its Total Shareholder’s Equity was $928.01M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.63.
